Residual anti-Xa activity in plasma of patients presenting for electively planned neuraxial regional anesthesia. Knoerlein J, Brodbeck P, Buchsel M, Zieger B, et al. Reg Anesth Pain Med 2023 Jan 27:rapm-2022-104079. doi: 10.1136/rapm-2022-104079.

Read + Share

Amedeo Smart

Independent Medical Education

Knoerlein J, Brodbeck P, Buchsel M, Zieger B, et al. Residual anti-Xa activity in plasma of patients presenting for electively planned neuraxial regional anesthesia. Reg Anesth Pain Med 2023 Jan 27:rapm-2022-104079. doi: 10.1136/rapm-2022-104079.
PMID: 36707225